Curis (CRIS) Capital Expenditures Growth (5y) (2015 - 2022)
Curis (CRIS) Capital Expenditures Growth (5y) (2015 - 2022) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Curis |
8.58 Mn |
-6.42 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2022 |
19.88% |
| Jun 30, 2022 |
36.68% |
| Mar 31, 2022 |
-26.70% |
| Sep 30, 2020 |
36.78% |
| Jun 30, 2020 |
543.10% |
| Mar 31, 2020 |
11.69% |
| Sep 30, 2019 |
42.81% |
| Sep 30, 2018 |
-5.00% |
| Mar 31, 2018 |
17.11% |
| Dec 31, 2017 |
-8.18% |
| Sep 30, 2017 |
19.79% |
| Jun 30, 2017 |
26.17% |
| Mar 31, 2017 |
37.69% |
| Dec 31, 2016 |
40.64% |
| Sep 30, 2016 |
33.01% |
| Jun 30, 2016 |
3.70% |
| Mar 31, 2016 |
-27.37% |
| Sep 30, 2015 |
-10.13% |
